In this installment of 5-Star Friday — our regular feature highlighting excellent health care writing that caught our eye — we noticed a bit of a common thread. Our publisher Gary Schwitzer called it “a step away from the norm of the daily drumbeat.”
The topics covered below are ones you’ll read about week after week. So it’s easy to fall in step with that beat, and march to the same old drummer.
But we feel the reporting featured below doesn’t do that. See if you agree.
How cool that CNN afforded the time and space for a journalist to explore a big picture issue such as a history of past successes and failures with vaccines. How wonderful to see a 3,000 word online piece. How important it is to allow journalists to step back from the shovelware, spoonfed, journal du jour news that dominates most of the health care news landscape – and to, instead, provide history, background, context, perspective.
That’s what I thought we’d be allowed to do when I worked for CNN medical news in the pre-Internet caveman era (1984-1990). But, alas, management didn’t afford us that luxury. And when we were given a new opportunity to produce one-hour specials, they were pharma-sponsored and ethical disputes arose. It was a constant frustration and this reporter eventually walked away in disgust and disappointment.
Maybe now there’s a little light flickering on the horizon? “It is better to light one candle than to curse the darkness.”
Haven’t you been wondering the same thing?
This story takes a step back from the stream of bad news about Alzheimer’s research to recruit the views of three experts. It addresses why a focus on amyloid plaques — protein clumps that seem to block signalling in the brain — has been such a bust.
“Ten years ago, there was very little funding for Alzheimer’s disease,” James Hendrix, director of global science initiatives for the Alzheimer’s Association, told Thompson. “When you don’t have a lot of money for funding, you tend to go for the most obvious approach, and that was amyloid.”
Better technology has since revealed that about a third of people with Alzheimer’s don’t have these plaques, the story reports.
Meanwhile, more funding for Alzheimer’s research has helped open new avenues of study, such as the Tau protein and how other health conditions associated with aging might contribute. “So researchers have started thinking that any successful treatment for Alzheimer’s will resemble the ‘cure’ that HIV patients are given — a multi-pronged drug and lifestyle regimen that keeps their illness at bay,” Thompson writes.
I wish more journalists would step back from the daily mill of news releases to explain the bigger picture.
We’ve published dozens of articles about the news coverage of concussion; most recently this piece touching on how the NFL frames this issue for the public.
It’s an area where you have to be careful as a reader because it can be a minefield of conflicts of interest, mouse studies that reporters will carelessly extrapolate to humans, and clickbait headlines that overreach in spinning results from observational studies.
In navigating this maze it’s often easy to overlook that at the center of these stories are people getting hurt.
And that’s the power of this roughly 5-minute film featuring all 281 reported concussions from the 2017 NFL season. You have no choice but to acknowledge this pain. The overall effect of the film is paradoxically mesmerizing and deeply disturbing. Kudos to Begley for trying a new way to reach people with this important health issue.
And may I add an important reminder that I think is not covered nearly enough? That is, these concussions are occurring in a variety of settings that bring up important public health issues. A short list would include falls in the elderly, domestic violence, bicycle and car accidents, and a host of sports besides just American football.
The article is a few months old, but seems worthy given the grassroots efforts to spur new gun control legislation after the school shooting in Parkland, Florida. It also fits our 5-star theme of engaging deep perspectives behind the issues of the day.
Melinda Wenner Moyer takes an in-depth look at gun ownership and crime in the US. She sets her exploration of the scientific evidence alongside on-the-ground reporting from Southern towns where guns are a part of life.
Wenner Moyer reminds readers that the evidence base is small because of restrictions placed on the CDC from conducting gun violence research as a public health issue. (Also, it’s implausible to design a controlled experiment.) The issue is highly polarized, which means advocates on either side of the gun control debate tend to cherry-pick studies that support their positions. For an example, read this published “objection” to Wenner Moyer’s article and the author’s response.
Please Note: These stories have not been subject to our rigorous, 10-criteria systematic review for accuracy, balance, and completeness. Rather, they represent pieces of health care journalism that members of our staff found compelling and wanted to share with others.
5-Star Friday is a regular feature on HealthNewsReview.org. You can find a list of previous installments HERE.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like